Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes.

MLA

Jang, Tyng‐Yuan, et al. “Amelioration of Glucose Intolerance through Directly Acting Antiviral Agents in Chronic Hepatitis C Cirrhotic Patients without Overt Diabetes.” Kaohsiung Journal of Medical Sciences, vol. 38, no. 9, Sept. 2022, pp. 897–906. EBSCOhost, https://doi.org/10.1002/kjm2.12563.

APA

Jang, T., Lin, Y., Liang, P., Yeh, M., Huang, C., Liu, T., Wei, Y., Hsu, P., Yang, J., Hou, N., Wang, C., Hsieh, M., Lin, Z., Huang, C., Huang, J., Dai, C., Chuang, W., & Yu, M. (2022). Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes. Kaohsiung Journal of Medical Sciences, 38(9), 897–906. https://doi.org/10.1002/kjm2.12563

Chicago

Jang, Tyng‐Yuan, Yi‐Hung Lin, Po‐Cheng Liang, Ming‐Lun Yeh, Ching‐I Huang, Ta‐Wei Liu, Yu‐Ju Wei, et al. 2022. “Amelioration of Glucose Intolerance through Directly Acting Antiviral Agents in Chronic Hepatitis C Cirrhotic Patients without Overt Diabetes.” Kaohsiung Journal of Medical Sciences 38 (9): 897–906. doi:10.1002/kjm2.12563.